Status:
RECRUITING
Remote Symptom Monitoring on Patient-Reported Outcomes With Nudge Strategies Among Patients With Tumor in China
Lead Sponsor:
Wei Xiaoping
Conditions:
Hepatocellular Carcinoma (HCC)
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to design a digital PRO intervention model applicable to patients with hepatocellular carcinoma, and The main questions it aims to answer are: * Can symptom managem...
Eligibility Criteria
Inclusion
- The patients are aged between 18 and 75 years old;
- The patients have been diagnosed with locally advanced or metastatic liver cancer through pathological or imaging examinations;
- The patients are currently receiving or have completed PD-1 monotherapy or PD-1 combination therapy;
- The patients can participate in this study as per the requirements of the research protocol;
- The patients voluntarily sign the informed consent form.
Exclusion
- The patients have cognitive impairment or are unable to clearly identify their own symptoms and feelings;
- The patients are illiterate or unable to understand the research content for other reasons;
- The patients are currently participating in other clinical trials that may affect this study.
Key Trial Info
Start Date :
May 24 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06938945
Start Date
May 24 2025
End Date
December 31 2025
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Center for Health Development Studies, Peking University
Haidian, Beijing Municipality, China, 100191